Authored by Gloria Bachmann, MD and Nancy Phillips, MD, the new ACCELERATE Abstract summarizes a study that compares time to symptomatic relief for DIFLUCAN® (fluconazole) and MONISTAT® (miconazole). In the vulvovaginal candidiasis (VVC) treatment category, fluconazole is recognized as the leading prescription pill, while MONISTAT® is the leading over-the-counter treatment.

In the randomized, double parallel group study, 300 women were treated with either MONISTAT® 1 Combination Pack or DIFLUCAN® (fluconazole) 150 mg. There was a statistically significant difference in time to onset of relief of itching, irritation, and overall symptoms between treatment groups.

In the clinical study with 300 patients, MONISTAT® relieved itching, burning, and irritation 4x faster than DIFLUCAN®

MONISTAT® vs Fluconazole VVC Symptom Relief

a Kaplan-Meier analysis based on overall time to event curves

View the abstract

*Based on a clinical study with MONISTAT® 1 Combination Pack Ovule® treatment vs the leading prescription product.